Tempest Therapeutics, Inc. Operating Cash Flow
Tempest Therapeutics, Inc. (TPST) reported Operating Cash Flow of -$10.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.78M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$7.60M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.57M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.78M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$26.82M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$33.03M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$27.36M.
- Tempest Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$31.07M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$10.38M 10-Q · filed 2026-08-13 | -$13.95M derived: sum of 3 quarters · filed 2026-08-13 | -$20.73M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$7.60M 10-Q · filed 2026-05-14 | -$11.17M derived: sum of 2 quarters · filed 2026-05-14 | -$17.95M derived: sum of 3 quarters · filed 2026-05-14 | -$26.38M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$10.35M derived: sum of 2 quarters · filed 2026-03-30 | -$18.78M derived: sum of 3 quarters · filed 2026-08-13 | -$26.82M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | -$6.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$15.21M derived: sum of 2 quarters · filed 2026-08-13 | -$23.25M 10-Q · filed 2025-11-05 | -$33.40M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$16.47M 10-Q · filed 2026-08-13 | -$26.62M derived: sum of 3 quarters · filed 2026-08-13 | -$36.80M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$8.04M 10-Q · filed 2026-05-14 | -$18.18M derived: sum of 2 quarters · filed 2026-05-14 | -$28.37M derived: sum of 3 quarters · filed 2026-05-14 | -$33.88M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | -$10.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$20.33M derived: sum of 2 quarters · filed 2026-03-30 | -$25.84M derived: sum of 3 quarters · filed 2026-03-30 | -$33.03M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | -$10.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$15.69M derived: sum of 2 quarters · filed 2025-11-05 | -$22.88M 10-Q · filed 2025-11-05 | -$29.05M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$5.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$12.70M 10-Q · filed 2025-08-11 | -$18.87M derived: sum of 3 quarters · filed 2025-08-11 | -$25.36M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | -$7.19M 10-Q · filed 2025-05-13 | -$13.36M derived: sum of 2 quarters · filed 2025-05-13 | -$19.85M derived: sum of 3 quarters · filed 2025-05-13 | -$26.24M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$12.66M derived: sum of 2 quarters · filed 2025-03-27 | -$19.05M derived: sum of 3 quarters · filed 2025-03-27 | -$27.36M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$6.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$12.88M derived: sum of 2 quarters · filed 2024-11-12 | -$21.18M 10-Q · filed 2024-11-12 | -$27.66M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$14.70M 10-Q · filed 2024-08-08 | -$21.17M derived: sum of 3 quarters · filed 2024-08-08 | -$30.25M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$8.30M 10-Q · filed 2024-05-09 | -$14.78M derived: sum of 2 quarters · filed 2024-05-09 | -$23.85M derived: sum of 3 quarters · filed 2024-05-09 | -$32.27M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$6.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$15.55M derived: sum of 2 quarters · filed 2024-03-19 | -$23.96M derived: sum of 3 quarters · filed 2024-03-19 | -$31.07M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | -$9.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$17.49M derived: sum of 2 quarters · filed 2023-11-08 | -$24.59M 10-Q · filed 2023-11-08 | -$32.58M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$8.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$15.52M 10-Q · filed 2023-08-10 | -$23.51M derived: sum of 3 quarters · filed 2023-08-10 | -$35.30M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$7.11M 10-Q · filed 2023-05-10 | -$15.09M derived: sum of 2 quarters · filed 2023-05-10 | -$26.88M derived: sum of 3 quarters · filed 2023-05-10 | -$26.75M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$19.77M derived: sum of 2 quarters · filed 2023-03-22 | -$19.65M derived: sum of 3 quarters · filed 2023-03-22 | -$25.96M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$11.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$11.66M derived: sum of 2 quarters · filed 2022-11-08 | -$17.97M 10-Q · filed 2022-11-08 | -$22.25M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$6.18M 10-Q · filed 2022-08-15 | -$10.46M derived: sum of 3 quarters · filed 2022-08-15 | -$15.08M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | -$6.31M 10-Q · filed 2022-05-13 | -$11.84M 10-Q · filed 2021-05-13 | -$10.58M derived: sum of 2 quarters · filed 2022-05-13 | -$15.21M derived: sum of 3 quarters · filed 2022-05-13 | -$15.17M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$8.90M derived: sum of 2 quarters · filed 2022-03-29 | -$8.86M derived: sum of 3 quarters · filed 2022-03-29 | -$19.02M 10-K · filed 2022-03-29 | -$30.43M 10-K · filed 2021-03-29 | |||
| 2020-09-30 | -$4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$4.58M derived: sum of 2 quarters · filed 2021-11-10 | -$14.74M 10-Q · filed 2021-11-10 | -$25.13M 10-Q · filed 2020-11-09 | -$26.43M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$10.12M 10-Q · filed 2021-08-12 | -$18.03M 10-Q · filed 2020-08-10 | -$21.81M derived: sum of 3 quarters · filed 2021-08-12 | -$30.17M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$10.16M 10-Q · filed 2021-05-13 | -$21.85M derived: sum of 2 quarters · filed 2021-05-13 | -$30.21M derived: sum of 3 quarters · filed 2021-05-13 | -$40.78M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$11.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$20.05M derived: sum of 2 quarters · filed 2021-03-29 | -$30.62M derived: sum of 3 quarters · filed 2021-03-29 | -$41.22M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$8.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$18.93M derived: sum of 2 quarters · filed 2020-11-09 | -$29.53M 10-Q · filed 2020-11-09 | -$38.76M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$10.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$21.17M 10-Q · filed 2020-08-10 | -$30.40M derived: sum of 3 quarters · filed 2020-08-10 | -$35.12M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$10.60M 10-Q · filed 2020-05-08 | -$19.83M derived: sum of 2 quarters · filed 2020-05-08 | -$24.55M derived: sum of 3 quarters · filed 2020-05-08 | -$29.25M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$9.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$13.95M derived: sum of 2 quarters · filed 2020-03-11 | -$18.65M derived: sum of 3 quarters · filed 2020-03-11 | -$23.65M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$4.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$9.42M derived: sum of 2 quarters · filed 2019-11-13 | -$14.42M 10-Q · filed 2019-11-13 | -$21.49M 10-Q · filed 2018-11-09 | $2.82M derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | -$4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$9.70M 10-Q · filed 2019-08-12 | -$13.76M 10-Q · filed 2018-08-09 | $7.54M derived: sum of 3 quarters · filed 2019-08-12 | -$2.76M derived: sum of 4 quarters · filed 2019-08-12 | |||
| 2018-03-31 | -$5.00M 10-Q · filed 2019-05-15 | -$8.93M 10-Q · filed 2018-05-03 | $12.24M derived: sum of 2 quarters · filed 2019-05-15 | $1.94M derived: sum of 3 quarters · filed 2019-05-15 | -$10.15M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $17.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.93M derived: sum of 2 quarters · filed 2019-04-01 | -$5.16M derived: sum of 3 quarters · filed 2019-04-01 | -$20.34M 10-K · filed 2019-04-01 | -$45.55M 10-K · filed 2018-03-15 | |||
| 2017-09-30 | -$10.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$22.39M derived: sum of 2 quarters · filed 2018-11-09 | -$37.58M 10-Q · filed 2018-11-09 | -$52.55M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$12.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$27.27M 10-Q · filed 2018-08-09 | -$42.24M derived: sum of 3 quarters · filed 2018-08-09 | -$57.68M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$15.19M 10-Q · filed 2018-05-03 | -$30.15M derived: sum of 2 quarters · filed 2018-05-03 | -$45.59M derived: sum of 3 quarters · filed 2018-05-03 | -$61.51M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | -$14.97M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$30.41M derived: sum of 2 quarters · filed 2018-03-15 | -$46.32M derived: sum of 3 quarters · filed 2018-03-15 | -$61.73M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | -$15.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$31.36M derived: sum of 2 quarters · filed 2017-11-02 | -$46.77M 10-Q · filed 2017-11-02 | -$58.08M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | -$15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$31.33M 10-Q · filed 2017-08-03 | -$42.65M derived: sum of 3 quarters · filed 2018-03-15 | -$55.17M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | -$15.41M 10-Q · filed 2017-05-09 | -$26.73M derived: sum of 2 quarters · filed 2018-03-15 | -$39.25M derived: sum of 3 quarters · filed 2018-03-15 | -$51.30M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | -$11.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$23.84M derived: sum of 2 quarters · filed 2018-03-15 | -$35.89M derived: sum of 3 quarters · filed 2018-03-15 | -$50.29M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | -$12.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$24.57M derived: sum of 2 quarters · filed 2016-11-03 | -$38.97M 10-Q · filed 2016-11-03 | -$49.49M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | -$12.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$26.45M 10-Q · filed 2016-08-04 | -$36.97M derived: sum of 3 quarters · filed 2017-03-02 | -$45.50M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | -$14.39M 10-Q · filed 2016-05-05 | -$24.92M derived: sum of 2 quarters · filed 2017-03-02 | -$33.45M derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2014-12-31 | -$10.52M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$19.06M derived: sum of 2 quarters · filed 2017-03-02 | -$30.59M 10-K · filed 2017-03-02 | |||||
| 2014-09-30 | -$8.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$20.06M 10-Q · filed 2015-11-05 | ||||||
| 2014-06-30 | -$11.53M 10-Q · filed 2015-08-10 | |||||||
| 2013-12-31 | -$18.09M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |